[1]
C. Dolapsakis, E. Karofylakis, and S. Chalvatzis, “Unmasking of normocalcemic primary hyperparathyroidism after sodium-glucose cotransporter-2 inhibitor initiation”, EJCRIM, vol. 12, no. 2, Jan. 2025, doi: 10.12890/2025_005169.